Kian Meng Chang

698 total citations
29 papers, 198 citations indexed

About

Kian Meng Chang is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Kian Meng Chang has authored 29 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 12 papers in Genetics and 8 papers in Immunology. Recurrent topics in Kian Meng Chang's work include Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Kian Meng Chang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Kian Meng Chang collaborates with scholars based in Malaysia, United Kingdom and Taiwan. Kian Meng Chang's co-authors include Jameela Sathar, Li‐Chia Chen, Ping Chong Bee, Siew Siang Chua, Gin Gin Gan, Chiann‐Yi Hsu, Cecile Phan, Tan Seng Beng, Rahman Jamal and Rong‐San Jiang and has published in prestigious journals such as Blood, PLoS ONE and BMC Cancer.

In The Last Decade

Kian Meng Chang

26 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kian Meng Chang Malaysia 8 100 71 33 28 22 29 198
Carlos Martínez‐Murillo Mexico 9 112 1.1× 42 0.6× 41 1.2× 21 0.8× 20 0.9× 63 266
Rakchha Chhetri Australia 9 151 1.5× 88 1.2× 26 0.8× 20 0.7× 47 2.1× 25 219
Stéphane Darre France 6 146 1.5× 65 0.9× 65 2.0× 35 1.3× 29 1.3× 8 246
Ajoy Dias United States 9 71 0.7× 50 0.7× 41 1.2× 57 2.0× 11 0.5× 27 216
Daniela Piccioni Italy 8 75 0.8× 47 0.7× 92 2.8× 64 2.3× 11 0.5× 22 221
Nydia Strachman Bacal Brazil 9 88 0.9× 75 1.1× 31 0.9× 36 1.3× 10 0.5× 41 209
Maria Åström Sweden 11 217 2.2× 68 1.0× 65 2.0× 81 2.9× 15 0.7× 22 306
Kaito Harada Japan 9 189 1.9× 28 0.4× 29 0.9× 59 2.1× 13 0.6× 46 252
Vladimir Chernitskiy United States 5 51 0.5× 19 0.3× 50 1.5× 17 0.6× 26 1.2× 5 234
S Saji Japan 8 54 0.5× 46 0.6× 19 0.6× 88 3.1× 8 0.4× 17 239

Countries citing papers authored by Kian Meng Chang

Since Specialization
Citations

This map shows the geographic impact of Kian Meng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kian Meng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kian Meng Chang more than expected).

Fields of papers citing papers by Kian Meng Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kian Meng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kian Meng Chang. The network helps show where Kian Meng Chang may publish in the future.

Co-authorship network of co-authors of Kian Meng Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kian Meng Chang. A scholar is included among the top collaborators of Kian Meng Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kian Meng Chang. Kian Meng Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chow, Yock Ping, et al.. (2022). Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel. BMC Medical Genomics. 15(1). 10–10. 2 indexed citations
3.
Kumar, Suresh, Heng Fong Seow, Kian Meng Chang, et al.. (2022). Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia. Journal of Immunology Research. 2022. 1–13. 2 indexed citations
5.
Tan, Sen Mui, Mahmoud Danaee, Farida Islahudin, et al.. (2022). Psychometric evaluation of Oral Mucositis Daily Questionnaire: A cross-cultural adaptation of the Malay version in multiethnic adult autologous stem cell transplant. Asia-Pacific Journal of Oncology Nursing. 10(2). 100180–100180. 1 indexed citations
6.
Tan, Sen Mui, et al.. (2021). Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura. Case Reports in Oncology. 14(3). 1814–1820.
8.
Tohit, Eusni Rahayu Mohd, et al.. (2019). Potential CD34 signaling through phosphorylated-BAD in chemotherapy-resistant acute myeloid leukemia. Journal of Receptors and Signal Transduction. 39(3). 276–282. 3 indexed citations
9.
Qian, Yuxin, et al.. (2019). Reference interval establishment of full blood count extended research parameters in the multi-ethnic population of Malaysia.. PubMed. 74(6). 534–536. 4 indexed citations
10.
Chang, Kian Meng, et al.. (2018). Microarray-based genomic analysis identifies germline and somatic copy number variants and loss of heterozygosity in acute myeloid leukaemia. 1 indexed citations
11.
Chang, Kian Meng, et al.. (2017). Fludarabine, High Dose Cytarabine and Granulocyte Colony-Stimulating Factor (FLAG) as Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study. Indian Journal of Hematology and Blood Transfusion. 33(4). 483–491. 2 indexed citations
12.
Beng, Tan Seng, et al.. (2017). Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study. Patient Preference and Adherence. Volume 11. 1027–1034. 14 indexed citations
14.
Chuncharunee, Suporn, Raymond Wong, Ponlapat Rojnuckarin, et al.. (2016). Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study. International Journal of Hematology. 104(4). 454–461. 18 indexed citations
15.
Gan, Gin Gin, Shamsul Mohd Zain, Batoul Sadat Haerian, et al.. (2014). Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population. Journal of Human Genetics. 59(5). 280–287. 6 indexed citations
16.
Chang, Kian Meng, et al.. (2014). Haematological Reference Intervals in a Multiethnic Population. PLoS ONE. 9(3). e91968–e91968. 55 indexed citations
17.
Phan, Cecile, et al.. (2011). Thalassaemia screening among students in a secondary school in Ampang, Malaysia.. PubMed. 66(5). 522–4. 16 indexed citations
18.
Chang, Kian Meng, et al.. (2011). The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms. Indian Journal of Hematology and Blood Transfusion. 27(3). 136–145. 1 indexed citations
19.
Gan, Gin Gin, et al.. (2008). Bone marrow and stem cell transplantation: Malaysian experience. Bone Marrow Transplantation. 42(S1). S103–S105. 13 indexed citations
20.
Chang, Kian Meng, et al.. (2008). Experience in Using Hypercvad Combined with Alemtuzumab in Treating Peripheral T-Cell and T/NK-Cell Neoplasms. Blood. 112(11). 5013–5013. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026